Using Mendelian Randomization (MR) with the inverse variance weighted method, we found that higher expression of DC-SIGN plasma protein was associated with increased COVID-19 risk (β=0.14, p=3.39×10−3) and severity (β=0.30, p=5.41×10−5; Supplementary Table S1). This evidence concerns the gene CD209 and COVID-19.